Intrust Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,412
| Closed | -$399K | – | 393 |
|
|
2021
Q2 | $399K | Sell |
2,412
-154
| -6% | -$25.7K | 0.05% | 261 |
|
|
2021
Q1 | $394K | Sell |
2,566
-419
| -14% | -$56.9K | 0.06% | 262 |
|
|
2020
Q4 | $375K | Sell |
2,985
-55
| -2% | -$6.15K | 0.06% | 254 |
|
|
2020
Q3 | $309K | Sell |
3,040
-7
| -0.2% | -$714 | 0.05% | 250 |
|
|
2020
Q2 | $296K | Buy |
+3,047
| New | +$284K | 0.06% | 263 |
|
|
2020
Q1 | – | Sell |
-1,966
| Closed | -$219K | – | 370 |
|
|
2019
Q4 | $219K | Buy |
+1,966
| New | +$202K | 0.05% | 319 |
|
|
2019
Q2 | – | Sell |
-2,154
| Closed | -$237K | – | 380 |
|
|
2019
Q1 | $237K | Buy |
+2,154
| New | +$225K | 0.06% | 346 |
|
|
2018
Q4 | – | Sell |
-2,216
| Closed | -$244K | – | 401 |
|
|
2018
Q3 | $244K | Sell |
2,216
-42
| -2% | -$4.37K | 0.06% | 336 |
|
|
2018
Q2 | $211K | Buy |
+2,258
| New | +$194K | 0.06% | 352 |
|
|
2018
Q1 | – | Sell |
-2,237
| Closed | -$204K | – | 382 |
|
|
2017
Q4 | $204K | Buy |
+2,237
| New | +$186K | 0.06% | 362 |
|
Other funds holding PRAH
Intrust Bank's PRAH Position: Q3 2021 in Review
Intrust Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,412 shares — an estimated $399K sold.
Intrust Bank first reported a position in PRAH in Q4 2017 and held it in 10 quarters. The position peaked at $399K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Intrust Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Intrust Bank sold 2,412 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $399K.
- Intrust Bank first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 10 quarters.
- Intrust Bank's PRA Health Sciences, Inc. position peaked at $399K in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Intrust Bank's 13F filing for Q3 2021, filed 4 Nov 2021.